Ovid Therapeutics, Inc. (OVID)
1.635
-0.02
(-0.91%)
USD |
NASDAQ |
Dec 12, 13:07
Ovid Therapeutics Research and Development Expense (Quarterly): 5.853M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| AnaptysBio, Inc. | 31.27M |
| Ionis Pharmaceuticals, Inc. | 217.13M |
| MannKind Corp. | 14.06M |
| Cassava Sciences, Inc. | 3.955M |
| Cidara Therapeutics, Inc. | 35.53M |